News | February 08, 2025
NURA AI Health Screening Centre Bengaluru celebrates 4th anniversary of transforming lives through early detection
Plans underway to expand screening capacity by 50% for greater accessibility
Plans underway to expand screening capacity by 50% for greater accessibility
Such combined efficacy (achieving clinical cure and microbiologic cure) of Zaynich is highest ever among all the FDA-approved novel antibiotics developed in the last more than 10 years
The Union Budget 2025-26 strengthens India's healthcare sector with an allocation of Rs. 99,858.56 crore, marking a 9.78% rise from Rs. 90,958.63 crore in 2024-25
Novel illumination system with key components molded in Radel® PPSU for durability and repeated sterilization
Expand the scope of the Production-Linked Incentive (PLI) scheme and increase its allocation to cover more pharmaceutical products and raw materials
If approved, sasanlimab would be the first PD-1 inhibitor, in combination with BCG, to significantly prolong event-free survival in this patient population
Nadda chairs Joint Strategy Meeting with Line Ministries for TB Mukt Bharat Abhiyan- 100-Day Intensified Campaign
Wockhardt plans to launch Miqnaf in the Indian market in coming few months
Mankind Pharma will have exclusive rights to register, import, market, sell and distribute sintilimab in India
Afrezza, developed by MannKind Corporation in the USA, offers a needle-free, rapid-acting insulin option for diabetes management
Subscribe To Our Newsletter & Stay Updated
